Theratechnologies (THTX) Announces Resignation of Alain Trudeau from Board

Theratechnologies Inc. (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Mr. Alain Trudeau has resigned from the Board of Directors of Theratechnologies and as a member of its Audit Committee, effective immediately.

“I want to thank Alain for his contributions to Theratechnologies as a director since joining the Company in October 2020 and for completing the annual review for the 2023 fiscal year”, said Dawn Svoronos, Chair of the Board at Theratechnologies. “Alain was the current Chair of the Audit Committee and, during his tenure as a Board member, he was also a member of the Compensation Committee from May 2021 until March 2023.”

Consistent with past practices, the Board of Directors of the Company will assess whether it will appoint a new member to fill this vacancy at the Board before the next annual meeting of shareholders.

The Board has appointed Frank Holler as Chair of the Audit Committee and plans to appoint a new independent director to this committee in order to ensure compliance with securities regulation.

You May Also Be Interested In

• Virtus Investment Partners names Jack Boyce to its board
• Azitra regains NYSE American listing compliance
• Synergy CHC gets Nasdaq notice over delayed quarterly filing